Recombinant Human GLI3 Protein: FAQs & Technical Guide

Recombinant Human GLI3 Protein is a research-grade zinc finger transcription factor central to Hedgehog pathway regulation, offering scientists a reliable tool for studying developmental signaling, limb patterning, and related disease mechanisms.

Product Name

Recombinant Human GLI3 Protein

SKU

rp377004

Protein Family

GLI family zinc finger transcription factors (Hedgehog signaling effectors)

Biological Role

Acts as both transcriptional activator and repressor downstream of Hedgehog signaling; critical for embryonic development and limb patterning

Associated Disease

Loss-of-function mutations linked to Greig cephalopolysyndactyly syndrome and Pallister-Hall syndrome

Recommended Storage

-20°C or -80°C; avoid repeated freeze-thaw cycles

Supplier

Aladdin Scientific

What Is GLI3 and Why Is It Important in Research?

GLI3 (GLI Family Zinc Finger 3) is a member of the Krüppel-like zinc finger transcription factor family and a key downstream effector of the Hedgehog (Hh) signaling pathway. The human GLI3 gene encodes a large protein that undergoes proteolytic processing to generate either a full-length transcriptional activator (GLI3A) or a truncated transcriptional repressor (GLI3R), depending on the presence or absence of Hedgehog ligand stimulation.

GLI3 plays essential roles in embryonic development, including limb patterning, brain formation, and skeletal morphogenesis. Mutations in GLI3 are associated with several human congenital disorders, most notably Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS), making it a clinically relevant target for developmental biology and rare disease research.

In oncology research, aberrant Hedgehog/GLI3 signaling has been implicated in multiple cancers, broadening the relevance of GLI3 protein to translational and therapeutic studies.

Product Specifications and Quality Attributes

Recombinant Human GLI3 Protein (SKU: rp377004) is manufactured to research-grade standards suitable for use in biochemical and cell-based assays. The following specifications are typical for recombinant proteins of this class; researchers should consult the Certificate of Analysis (CoA) supplied with each lot for confirmed lot-specific values:

• Expression System: Typically produced in a mammalian or insect cell expression system to support proper folding and post-translational modifications relevant to GLI3 function. Confirm system on the product datasheet.
• Purity: Expected to be ≥85% by SDS-PAGE; lot-specific purity is confirmed on the CoA.
• Formulation: Supplied as a lyophilized powder or liquid; consult the product datasheet for the exact buffer composition and formulation details.
• Endotoxin Level: Typically <1.0 EU/μg as determined by LAL assay; verify on lot CoA.
• Biological Activity: Functional activity should be confirmed using an appropriate Hedgehog pathway reporter assay or binding assay; refer to the datasheet for validated assay formats.

All specific numerical values (molecular weight, exact purity thresholds, endotoxin limits) should be verified against the current product datasheet and CoA available from Aladdin Scientific.

Reconstitution, Handling, and Storage Guidelines

Proper handling of Recombinant Human GLI3 Protein is critical to preserving biological activity and maximizing shelf life. Follow these general best-practice guidelines:

Reconstitution

• If supplied as a lyophilized powder, allow the vial to equilibrate to room temperature before opening to minimize condensation.
• Reconstitute in the buffer recommended on the product datasheet (typically sterile PBS or a carrier protein-containing buffer such as 0.1% BSA in PBS). Pipette gently; do not vortex.
• Allow the protein to dissolve completely for 10–15 minutes at room temperature or on ice before use.

Aliquoting

• Prepare single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which degrade protein integrity and reduce activity.

Storage

• Store lyophilized protein at -20°C. Once reconstituted, store aliquots at -80°C for long-term use or at 4°C for short-term use (typically up to one week).
• Avoid repeated freeze-thaw cycles (limit to ≤3 cycles maximum).
• Adding a carrier protein (e.g., 0.1% BSA) to the working solution can help stabilize the protein during storage.

Always refer to the specific storage and handling instructions provided on the Aladdin Scientific product datasheet for this lot, as formulation details may vary.

Common Research Applications of GLI3 Protein

Recombinant Human GLI3 Protein supports a broad range of research applications in developmental biology, cancer biology, and drug discovery:

• Hedgehog Pathway Studies: GLI3 is used to dissect the molecular mechanisms of Hh signal transduction, including activator/repressor switching and interaction with pathway components such as SUFU, PKA, and CUL3.
• Protein–Protein Interaction Assays: Suitable for co-immunoprecipitation (Co-IP), pull-down assays, and surface plasmon resonance (SPR) to characterize GLI3 binding partners.
• DNA-Binding Studies: Electrophoretic mobility shift assays (EMSA) and ChIP experiments to study GLI3 binding to target gene promoters containing the consensus GLI-binding sequence (5'-GACCACCCA-3').
• Drug Discovery and Screening: Used as a target protein in small-molecule inhibitor screening campaigns aimed at modulating Hedgehog pathway activity in cancer or developmental disorders.
• Structural and Biochemical Studies: Supports crystallography, cryo-EM, and biophysical characterization of the GLI3 zinc finger domain and other structural features.
• Antibody Validation: Serves as a positive control antigen for validating anti-GLI3 antibodies in Western blot, ELISA, and immunofluorescence assays.

Researchers should validate the protein for each specific application and optimize assay conditions using appropriate controls.

Troubleshooting Common Issues with GLI3 Protein Experiments

Researchers may encounter the following challenges when working with Recombinant Human GLI3 Protein. The table below outlines common issues and recommended corrective actions:

• Low or No Detected Activity: Ensure the protein has been reconstituted according to the datasheet. Verify that freeze-thaw cycles have not exceeded the recommended maximum. Check that the assay buffer is compatible and that the protein concentration used is within the validated range. Confirm the detection antibody recognizes the recombinant form.
• Protein Precipitation or Aggregation: GLI3 is a large protein prone to aggregation. Reconstitute gently, keep the protein on ice during handling, add carrier protein (0.1% BSA), and avoid concentrations exceeding recommended working concentrations.
• Unexpected Band Size on Western Blot: GLI3 undergoes proteolytic processing generating multiple isoforms (full-length activator ~190 kDa; repressor form ~83 kDa). Confirm which isoform or fragment your recombinant protein corresponds to by checking the datasheet.
• High Background in Binding Assays: Use blocking buffers appropriate for the assay format. Include negative controls (no protein or irrelevant protein). Titrate protein concentration to identify optimal signal-to-noise conditions.
• Inconsistent Results Between Lots: Always request the CoA for each lot and verify key quality parameters. Contact Aladdin Scientific technical support if lot-to-lot variability is suspected.

For unresolved issues, contact Aladdin Scientific customer and technical support with your lot number and CoA details.

Frequently asked questions

What is the difference between the GLI3 activator and repressor forms, and which form does rp377004 represent?

GLI3 exists as a full-length transcriptional activator (GLI3A, ~190 kDa) in the presence of Hedgehog signaling, and is proteolytically processed into a truncated transcriptional repressor (GLI3R, ~83 kDa) in the absence of Hh ligand. The specific isoform or domain represented by rp377004 should be confirmed by reviewing the product datasheet or contacting Aladdin Scientific technical support, as the recombinant construct may cover a defined region or full-length sequence.

What expression system is used to produce Recombinant Human GLI3 Protein (rp377004), and does it affect post-translational modifications?

The expression system for rp377004 should be confirmed on the Aladdin Scientific product datasheet, as this information is lot- and supplier-specific. In general, mammalian expression systems (e.g., HEK293) best replicate human post-translational modifications such as phosphorylation and ubiquitination that are critical to GLI3 activator/repressor processing. Insect cell (baculovirus) systems offer an intermediate, while E. coli-derived proteins lack eukaryotic modifications and may require refolding. Selecting the correct expression system is important if you require a functionally active protein.

How should I reconstitute and store Recombinant Human GLI3 Protein to maintain activity?

If supplied lyophilized, allow the vial to reach room temperature before opening, then reconstitute gently in the buffer specified on the datasheet (commonly sterile PBS with 0.1% BSA). Prepare single-use aliquots immediately and store at -80°C for long-term use. Avoid more than 2–3 freeze-thaw cycles, as repeated cycling significantly reduces activity. Short-term working stocks may be kept at 4°C for up to one week. Always follow the specific instructions on the Aladdin Scientific datasheet for this product.

Is Recombinant Human GLI3 Protein suitable for use in cell-based Hedgehog pathway reporter assays?

GLI3 protein is primarily used in cell-free biochemical assays such as protein binding studies, EMSA, and antibody validation rather than direct addition to cell culture media, because extracellular delivery of transcription factors into the nucleus is inefficient without specialized delivery systems. For cell-based Hedgehog reporter assays, researchers typically overexpress GLI3 via plasmid transfection or use the recombinant protein in cell-free nuclear extract systems. Please consult Aladdin Scientific technical support for guidance on application-specific use.

How do I verify the identity and purity of the GLI3 protein I received?

Each shipment of rp377004 is accompanied by a Certificate of Analysis (CoA) that documents lot-specific purity (typically assessed by SDS-PAGE and/or HPLC), identity (commonly confirmed by Western blot using an anti-GLI3 antibody or by mass spectrometry), and endotoxin levels. Upon receipt, compare the vial label information with the CoA. You may also run an SDS-PAGE or Western blot in-house using the provided CoA data as reference. Contact Aladdin Scientific if any discrepancy is observed.

References

1. Hui CC, Angers S. Gli proteins in development and disease. Annu Rev Cell Dev Biol. 2011;27:513-537. doi:10.1146/annurev-cellbio-092910-154048
2. Kogerman P, Grimm T, Kogerman L, et al. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol. 1999;1(5):312-319. doi:10.1038/13031
3. Kalff-Suske M, Wild A, Topp J, et al. Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome. Hum Mol Genet. 1999;8(9):1769-1777. doi:10.1093/hmg/8.9.1769
4. Aladdin Scientific. Recombinant Human GLI3 Protein (rp377004) Product Datasheet. Aladdin Scientific; [current version].

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.